Symbicort Aerosol
Product Images NDC 50090-4508

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Symbicort (NDC 50090-4508). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure1bodytext)

A line chart showing the percent change from baseline in percent predicted FEV1 over 12 weeks for different treatment groups with SYMBICORT 160/4.5 mcg, budesonide alone, formoterol alone, budesonide plus formoterol, and placebo. The x-axis represents the weeks of treatment, and the y-axis shows the percent change in FEV1. Group sizes at various time points are noted below the chart.*

FDA Label Image

Figure 2 (Figure2bodytext)

A line graph showing the percent change from baseline in predose FEV1 over a 12-week period for SYMBICORT 80/4.5 mcg, Budesonide 80 mcg, Formoterol 4.5 mcg, and placebo. The x-axis represents weeks, and the y-axis represents percent change in FEV1. The graph compares lung function improvements among treatment groups with sample sizes indicated at several time points.*

FDA Label Image

Figure 3 (Figure3bodytext)

A line graph depicting the percent change from baseline in FEV1 over 12 hours for different treatments. It compares SYMBICORT 160/4.5 mcg, Budesonide 160 mcg, Formoterol 4.5 mcg, a combination of Budesonide 160 mcg + Formoterol 4.5 mcg, and placebo. The x-axis represents time in hours, and the y-axis shows percent change from baseline in FEV1.*

FDA Label Image

Figure 4 (Figure4bodytext)

A line graph presenting the percent change from baseline in FEV1 over 12 hours for different treatment groups including SYMBICORT 160/4.5 mcg, Budesonide 160 mcg, Formoterol 4.5 mcg, Budesonide plus Formoterol combination, and placebo. The x-axis shows time in hours, and the y-axis shows percent change from baseline in FEV1. Data points represent various inhalation treatments with SYMBICORT showing the highest improvement over time.*

FDA Label Image

Figure 5 (Figure5bodytext)

A line graph comparing the change from baseline in 1-hour post-dose FEV1 (L) over 12 weeks between SYMBICORT 80/4.5 mcg (two inhalations twice daily) and Budesonide 80 mcg (two inhalations twice daily). The graph includes data points at multiple weeks and shows the number of patients at each assessment.*

FDA Label Image

Figure 6 (Figure6bodytext)

A line graph showing the percent change from baseline in pre-dose FEV1 over a 6-month period for different treatment groups: SYMBICORT MDI 160/4.5 mcg, Budesonide 160 mcg, Formoterol 4.5 mcg, Budesonide 160 mcg + Formoterol 4.5 mcg, and placebo. The graph includes sample sizes at each time point and differentiates groups by distinct markers.*

FDA Label Image

Figure 7 (Figure7bodytext)

A line graph illustrating the percent change from baseline in 1-hour post-dose FEV1 over six months for different treatments: SYMBICORT MDI 160/4.5 mcg, Budesonide 160 mcg, Formoterol 4.5 mcg, Budesonide 160 mcg + Formoterol 4.5 mcg, and Placebo, each administered as two inhalations twice daily. The graph includes sample sizes at each time point and the end of treatment.*

FDA Label Image

Budesonide Structural Formula (Image 01)

Chemical structure diagram showing two active ingredients of SYMBICORT: Budesonide and Formoterol Fumarate Dihydrate. The image depicts molecular structures with labeled chemical bonds characteristic of these compounds used in respiratory inhalation aerosol form.*

FDA Label Image

Structural Fumarate (Image 02)

Chemical structure of Budesonide and Formoterol Fumarate Dihydrate, the active ingredients in SYMBICORT inhalation aerosol. The diagram shows molecular components including formate and water molecules as part of the compound.*

FDA Label Image

Figure 1 (Image 03)

An instructional illustration showing a labeled diagram of a respiratory inhaler with parts identified including the counter, canister inside, inhaler, mouthpiece, strap, and mouthpiece cover. The diagram is a simplified drawing intended to depict the components of an aerosol inhaler device.*

FDA Label Image

Figure 2 (Image 04)

Illustration of a person holding a Symbicort aerosol inhaler, demonstrating the action of removing the gray protective cap by pulling it downward and away from the inhaler.*

FDA Label Image

Figure 3 (Image 05)

An instructional illustration showing a hand holding a red and gray Symbicort aerosol inhaler with the mouthpiece open and mist being released from the nozzle, demonstrating how to use the inhaler for respiratory administration.*

FDA Label Image

Figure 4 (Image 06)

An instructional diagram showing hands using a respiratory inhaler device, with the inhaler tip directed towards a fingertip and dosage being released as particles or mist. The image illustrates proper inhaler usage technique.*

FDA Label Image

Figure 5 (Image 07)

An instructional illustration showing a person using an inhaler device. The inhaler is held near the mouth with the mouthpiece inside the mouth, and the protective cap is hanging below the inhaler.*

FDA Label Image

Counter (arrow pointing to 80)

An instructional dial illustration showing a circular scale from 0 to 120, with a black arrow pointing near 80. The dial includes shaded segments between 0-10 and 20-30. This likely represents a dose counter or similar mechanism for the SYMBICORT inhaler device.*

FDA Label Image

Counter (arrow pointing to 15)

An illustration of a circular, numbered dial or counter ranging from 0 to 120, marked in increments of 10. A shaded segment highlights the range from 0 to 30, with an indicator arrow pointing near 25. The dial is most likely a dose counter for a respiratory inhalation aerosol product.*

FDA Label Image

Label Image (Lbl500904508)

Label for SYMBICORT 160/4.5 inhalation aerosol by A-S Medication Solutions. The label details each actuation delivers 160 mcg of budesonide and 4.5 mcg of formoterol fumarate dihydrate, with a 60 inhalation count. Storage instructions specify 68 to 77 degrees Fahrenheit and to store the inhaler with the mouthpiece down. Label includes NDC 50090-4508 and distributor information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.